The uptake level of [111In]In-DOTA-cetuximab in the EGFR highly-overexpressed HCC827 tumor (n = 7) was significantly higher than those in other cell lines except for EBC-1 (26.9 ± 3.10%ID/g, P < 0.05). This evidence concerns the gene EGFR and neoplasm.